Pages
Stay In Touch
More
© 2011, 2012 Health Futures Digest
Personalized Medicine and Cancer The discovery of multiple genes for colorectal cancer will lead to diagnostic, prognostic and therapeutic targets for the disease. In about two years, we may expect to have available a test for post-surgical colon cancer recurrence that will identify which patients might benefit from chemotherapy. We can expect a tsunami of […]
Genomic and Molecular Medicine After many attempts over the past two decades, genetically modified mosquitoes may finally have a chance of helping to eradicate the dengue fever with which mosquitoes annually infect 100 million people and cause 500,000 cases of dengue hemorrhagic fever and 22,000 deaths, mostly among children. For the disease of choroideraemia (rarer […]
Here’s our weekly summary of tweets from @hfdigest, and their significance. Genomic and Regenerative Medicine Until now, the known genetic markers for melanoma have all been associated with skin pigmentation or moles. Now, three have been found that are not associated in that way, which means that people with those markers may be at even […]
In the first (April) issue of this four-part series about regenerative medicine, we talked about the gold rush into stem cell territory, seen by venture capitalists, researchers, and clinicians to contain rich seams of untapped potential for providing significantly better medicine. In this issue, we provide specific examples of stem cell therapies under development and […]
Advisory Board on Regenerative Medicine According to the Advisory Board, patients who have suffered recent heart attacks are the main target of clinical trials of adult stem cells taken from bone marrow, muscle, or skin to repair heart tissue. The cells are taken from the patient’s own body or from a donor, and are transplanted […]
The genomic advances we wrote about in the last three issues are important contributors to another postmodern form of medicine: Regenerative medicine, the repair or replacement of tissue, organs, and limbs through cellular engineering inside the body or in the lab. In this issue, we digest reports of advances in regenerative medicine from just the […]
In this final part of our four-part series on regenerative medicine we digest reports of advances in engineering new tissues and organs, including methodologies and specific organs/tissues. We began the series by noting there is a “gold rush” of research and venture capital into regenerative medicine. In showing examples of nuggets unearthed so far, this […]
In last month’s issue we provided specific examples of stem cell therapies under development and in clinical trials. The emergence of such therapies shows why there is a “gold rush” of research and venture capital into regenerative medicine territory, as we discussed in the April issue. This month, we digest exemplary advances made over the […]
Advisory Board on Regenerative Medicine According to the Advisory Board, patients who have suffered recent heart attacks are the main target of clinical trials of adult stem cells taken from bone marrow, muscle, or skin to repair heart tissue. The cells are taken from the patient’s own body or from a donor, and are transplanted […]
The genomic advances we wrote about in the last three issues are important contributors to another postmodern form of medicine: Regenerative medicine, the repair or replacement of tissue, organs, and limbs through cellular engineering inside the body or in the lab. In this issue, we digest reports of advances in regenerative medicine from just the […]